The estimated Net Worth of Allan E Rubenstein is at least $6.14 Milión dollars as of 1 April 2020. Allan Rubenstein owns over 958 units of Cooper Companies stock worth over $439,357 and over the last 21 years he sold COO stock worth over $5,223,933. In addition, he makes $472,284 as Independent Vice Chairman of the Board a Lead Director at Cooper Companies.
Allan has made over 35 trades of the Cooper Companies stock since 2003, according to the Form 4 filled with the SEC. Most recently he exercised 958 units of COO stock worth $103,953 on 1 April 2020.
The largest trade he's ever made was exercising 30,300 units of Cooper Companies stock on 7 March 2011 worth over $1,315,626. On average, Allan trades about 1,512 units every 59 days since 2003. As of 1 April 2020 he still owns at least 4,049 units of Cooper Companies stock.
You can see the complete history of Allan Rubenstein stock trades at the bottom of the page.
Dr. Allan E. Rubenstein M.D. is no longer serves as Independent Vice Chairman of the Board, Lead Director of the Company effective 03/2021. Dr. Rubenstein has served as our Vice Chairman and Lead Director since July 2002, and previously served as Chairman of the Board from July 1994 through July 2002. He served as Acting Chairman of the Board from April 1993 through June 1994. He is a Clinical Professor of Neurology and Pediatrics at New York University Langone Medical Center. Formerly, he was Chief Executive Officer of NexGenix Pharmaceuticals in NYC from 2003 to 2011. He currently serves as Chairman of the Scientific Advisory Boards of Plex Pharmaceuticals in San Diego and Coloursmith in Halifax, Nova Scotia, both privately-held technology companies. He is a member of the Board of Advisors of the Sackler School Graduate Program in Biomedical Sciences at Tufts University. He is also the Founder and Medical Director Emeritus of the Children’s Tumor Foundation and a consultant to the National Institutes of Health, the U.S. Food and Drug Administration and the U.S. Department of Defense, where he served as Chair of the US Army Neurofibromatosis Research Program Integration Panel in 2001. Dr. Rubenstein was a Trustee of the Connecticut River Museum in Essex, CT from 2014-2019 and presently is a Director of the Lunenburg, Nova Scotia DocFest Film Festival.
As the Independent Vice Chairman of the Board a Lead Director of Cooper Companies, the total compensation of Allan Rubenstein at Cooper Companies is $472,284. There are 10 executives at Cooper Companies getting paid more, with Albert White having the highest compensation of $7,724,740.
Allan Rubenstein is 75, he's been the Independent Vice Chairman of the Board a Lead Director of Cooper Companies since 2002. There are 1 older and 18 younger executives at Cooper Companies. The oldest executive at Cooper Companies, Inc. is A. Thomas Bender, 80, who is the Independent Chairman of the Board.
Allan's mailing address filed with the SEC is C/O THE COOPER COMPANIES, INC., 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON, CA, 94583.
Over the last 21 years, insiders at Cooper Companies have traded over $45,273,696 worth of Cooper Companies stock and bought 5,157 units worth $1,262,486 . The most active insiders traders include Robert S Weiss, William A Kozy a Lawrence Erik Kurzius. On average, Cooper Companies executives and independent directors trade stock every 18 days with the average trade being worth of $1,325,775. The most recent stock trade was executed by Brian G Andrews on 5 September 2024, trading 24,788 units of COO stock currently worth $939,713.
company overview the cooper companies, inc. ("cooper") is a global medical device company publicly traded on the nyse euronext (nyse:coo). cooper is dedicated to being a quality of life company™ with a focus on delivering shareholder value. cooper operates through two business units, coopervision and coopersurgical. coopervision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. coopersurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. headquartered in pleasanton, ca, cooper has approximately 9,000 employees with products sold in over 100 countries. for more information, please visit www.coopercos.com.
Cooper Companies executives and other stock owners filed with the SEC include: